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Background: Conventionally the detection of hepatitis B
virus (HBV) DNA is carried out on serum using commercial or
in house PCR assays. Oral ﬂuid obtained by use of commer-
cial collection devices offers several advantages compared
to venepuncture: it is non invasive, painless, safe and less
expensive.
Methods: Seventy-three HBV DNA positive and 74 HBV
DNA negative paired serum/oral ﬂuid samples, drawn from
patients visiting university hospitals, were analysed. The
detection of HBV DNA in oral ﬂuid was carried out through
an optimised nested PCR with a 95% detection limit of
457 copies/ml
Results: A clinical sensitivity and speciﬁcity of 69.9%
(95%CI: 58.6%-79.2%) and 100% (95%CI: 95.1%-100.0%)
respectively was achieved. A statistically signiﬁcant asso-
ciation was found between the serum HBV DNA viral load
and the detection of HBV DNA in oral ﬂuid (p < 0.001). In
samples with a minimum concentration of 105 copies/ml
(high viraemia), it was possible to detect the virus in oral
ﬂuid in 91.8% (95%CI:80.8%-96.8%) of the cases. A concen-
tration of 105 copies/ml being considered as the minimum
level needed for the transmission of HBV via needlestick or
mucosal scratch, the optimised nested PCR could be used
in epidemiological surveys for mapping of active replicating
carriers.
Conclusion: An optimised nested PCR for HBV detection,
with a 95% detection limit of 457 copies/ml and a sensitivity
of 91.8% in patients with a minimum serum concentration of
105 copies/ml, was developed. The use of serum remains the
golden standard for individual diagnosis, monitoring of anti-
viral treatment or detection of occult infections. However,
oral ﬂuid sampling by oracol collection device offers through
all its advantages versus venepuncture a good alternative in
epidemiological and surveillance surveys.
doi:10.1016/j.ijid.2008.05.1335
71.011
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The haemagglutinin (HA) and neuramidase (NA) genes are
considered to be responsible for the major part of the anti-
genic variability of inﬂuenza A viruses. Reportedly, speciﬁc
amino acid changes might even serve as molecular markers
for the pandemic potential of avian inﬂuenza isolates.
We recently developed an Alignment & Mutation Analysis
tool as an extension library for the BioNumerics software.
Here, we illustrate the use of this versatile and power-
ful tool with publicly available sequences and trace ﬁles.
The latter were automatically assembled into contigs and
imported with the batch assembly plugin. Optimized set-
tings for trimming and assembly minimized manual editing.
Strain information was parsed along with the import and all
data were stored in a single relational database.
Using this plugin, we were able to assemble 22,000
inﬂuenza A genome sequence trace ﬁles from the NCBI Trace
Archive (http://0-ww.ncbi.nlm.nih.gov.catalog.llu.edu/
Traces/trace.cgi) in less than 30minutes. For the HA and
NA gene sequences of inﬂuenza A virus serotype H5N1,
a multiple alignment was created and the nucleic acid
sequences were translated into amino acids. Mutations
were searched relative to a consensus sequence, which
made ‘‘hot spots’’ for mutations to become immediately
apparent. For each mutation, its position, type (silent,
missense, indel), nucleotide change and amino acid change
was listed. When browsing through the mutation list, the
cursor jumps automatically to the corresponding position
on the alignment and curves, allowing the researcher to
visually evaluate the mutation in its context.
Overall, performing the complete mutation analysis
within a single software package offers much added ﬂexi-




C. Uhlenhaut ∗, A.M. Sierra-Honigmann, S. Nanda, S. Tang,
P.R. Krause
FDA/CBER, Bethesda, MD, USA
Reliable and fast assays are prerequisite for rapidly
identifying infectious agents such as emerging viruses,
zoonotically transmitted or otherwise rare and unusual
viruses in order to take appropriate epidemiologic actions
and/or to choose the best treatment. However, detection
and identiﬁcation of viruses without speciﬁc knowledge
about their genome can be challenging.
We developed an assay that combines virus capsid prepa-
ration with generic PCR. The ﬁrst step is the physical and
biochemical puriﬁcation of a given sample by targeted
digestion of contaminating host nucleic acids. This is fol-
lowed by a degenerate oligonucleotide primer (DOP) PCR.
The primer population is optimized for the detection of
virus-sized genomes. Products can be identiﬁed by cloning
and sequencing or by subjecting the PCR products to high
throughput sequencing. Various DNA viruses (including HSV,
VZV, SV40, AAV, EBV, parvoviruses and hepatitis B) and RNA
viruses (including HTLV-1 and HTLV-2, several animal retro-
viruses, poliovirus, hepatitis A, a human corona virus, human
metapneumovirus and inﬂuenza virus) were detected in cell
cultures and clinical samples.
This novel technique requires no prior sequence infor-
mation to amplify viral genomes, but nonetheless be able
to amplify at least a portion of each viral genome. It can
detect viruses in a variety of samples using only one aliquot
